Cargando…

Effect of age on response to anti-VEGF agents in patients with center involving diabetic macular edema in a tertiary hospital

PURPOSE: The aim of the current study is to evaluate the effect of age as an independent factor for the response to two anti-VEGF agents, intravitreal ranibizumab and intravitreal aflibercept, among patients presented with central-involving DME in one tertiary care center in Riyadh, Saudi Arabia. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alshalan, Hanan A., Arevalo, J. Fernando, Alomary, Saleh I., Ardah, Husam I., Hazzazi, Mohammd A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746215/ https://www.ncbi.nlm.nih.gov/pubmed/36514180 http://dx.doi.org/10.1186/s40942-022-00434-9

Ejemplares similares

Anti-VEGF for the Management of Diabetic Macular Edema
por: Stefanini, Francisco Rosa, et al.
Publicado: (2014)

Adjunct Intravitreous Triamcinolone Acetonide in the Treatment of Diabetic Macular Edema with Anti-VEGF Agents
por: Garoon, Robert B., et al.
Publicado: (2016)

Diabetic macular edema: it is more than just VEGF
por: Singer, Michael A., et al.
Publicado: (2016)

Combined Therapy for Diabetic Macular Edema
por: Al Rashaed, Saba, et al.
Publicado: (2013)

Review on Recent Trials Evaluating the Effect of Intravitreal Injections of Anti-VEGF Agents on the Macular Perfusion of Diabetic Patients with Diabetic Macular Edema
por: Elnahry, Ayman G., et al.
Publicado: (2020)

Vitrectomy for center-involved diabetic macular edema
por: Browning, David J, et al.
Publicado: (2016)

Correlation between macular vessel density and number of intravitreal anti-VEGF agents for macular edema associated with branch retinal vein occlusion
por: Tomita, Ryo, et al.
Publicado: (2019)

Visual and anatomic outcomes of sustained single agent anti-VEGF treatment versus double anti-VEGF switching in the treatment of persistent diabetic macular edema
por: Sorour, Osama A., et al.
Publicado: (2020)

Saudi Arabia Guidelines for diabetic macular edema: A consensus of the Saudi Retina Group
por: AlQahtani, Abdullah S., et al.
Publicado: (2021)

Vitreomacular interface after anti-VEGF injections in diabetic macular edema
por: Veloso, Carlos E., et al.
Publicado: (2021)

miRNA Levels as a Biomarker for Anti-VEGF Response in Patients with Diabetic Macular Edema
por: Vader, Maartje J. C., et al.
Publicado: (2021)

Diabetic Macular Edema: From Old Concepts to New Therapeutic Avenues
por: Mansour, Ahmad M, et al.
Publicado: (2015)

Outer retinal tubulation in diabetic macular edema following anti-VEGF treatment
por: Al-Halafi, Ali M
Publicado: (2015)

Dexamethasone Implant in Patients with Diabetic Macular Edema Resistant to Anti-VEGF Therapy
por: Nalçacı, Serhad, et al.
Publicado: (2019)

Combination of Anti-VEGF and Laser Photocoagulation for Diabetic Macular Edema: A Review
por: Distefano, Laura N., et al.
Publicado: (2017)

Glycemic Control after Initiation of Anti-VEGF Treatment for Diabetic Macular Edema
por: Oshima, Hideyuki, et al.
Publicado: (2022)

Cost-consequence analysis of extended loading dose of anti-VEGF treatment in diabetic macular edema patients
por: Ruiz-Moreno, J. M., et al.
Publicado: (2020)

Assessment of Anti-VEGFs in Treating Diabetic Macular Edema in Alfaisal Eye Center, Khartoum, Sudan, 2019
por: Ahmedalgabri, Rayan Hamza Mohammed, et al.
Publicado: (2022)

Outcomes of intravitreal bevacizumab and macular photocoagulation for treatment of diabetic macular edema in a tertiary care eye hospital, Karachi
por: Jafri, Adil Salim, et al.
Publicado: (2017)

Involvement of Cytokines in the Pathogenesis of Diabetic Macular Edema
por: Noma, Hidetaka, et al.
Publicado: (2021)

Relationship Between Macular Thickness and Visual Acuity in the Treatment of Diabetic Macular Edema With Anti-VEGF Therapy: Systematic Review
por: Wang, Patrick, et al.
Publicado: (2022)

Focal Laser Photocoagulation in Non-Center Involved Diabetic Macular Edema
por: Perente, Irfan, et al.
Publicado: (2014)

Pseudophakic macular edema involving epiretinal proliferation associated with macular hole
por: Batıoğlu, Figen, et al.
Publicado: (2020)

Intravitreal therapeutic agents in noninfectious uveitic macular edema
por: Shah, Kunal Kaushik, et al.
Publicado: (2018)

Switch to Aflibercept in Diabetic Macular Edema Patients Unresponsive to Previous Anti-VEGF Therapy
por: Mira, Filipe, et al.
Publicado: (2017)

Foveal Microvascular Integrity Association With Anti-VEGF Treatment Response for Diabetic Macular Edema
por: Huang, Wei-Hsuan, et al.
Publicado: (2021)

Behavior of SD-OCT Detectable Hyperreflective Foci in Diabetic Macular Edema Patients after Therapy with Anti-VEGF Agents and Dexamethasone Implants
por: Rübsam, Anne, et al.
Publicado: (2021)

Retrospective study of post-operative infections in implantable cardiac devices in a cardiac tertiary care center
por: Modi Atig, Alamer, et al.
Publicado: (2022)

Optical Coherence Tomography Angiography of Macular Perfusion Changes after Anti-VEGF Therapy for Diabetic Macular Edema: A Systematic Review
por: Elnahry, Ayman G., et al.
Publicado: (2021)

When is macular edema not macular edema? An update on macular telangiectasia type 2
por: Wu, Lihteh
Publicado: (2015)

Contrast Sensitivity Changes in Center Involving Diabetic Macular Edema Treated with Aflibercept
por: Nixon, Donald R, et al.
Publicado: (2021)

Retraction Note to: Pharmacological agents in development for diabetic macular edema
por: Sadiq, Mohammad Ali, et al.
Publicado: (2020)

Role of peripheral pan-retinal photocoagulation in diabetic macular edema treated with intravitreal ziv-aflibercept
por: Mansour, Ahmad M, et al.
Publicado: (2019)

Aqueous humor cytokine levels in patients with diabetic macular edema refractory to anti-VEGF treatment
por: Kwon, Jin-woo, et al.
Publicado: (2018)

Characteristics of diabetic macular edema patients refractory to anti-VEGF treatments and a dexamethasone implant
por: Choi, Moon Young, et al.
Publicado: (2019)

Factors Affecting a Short-Term Response to Anti-VEGF Therapy in Diabetic Macular Edema
por: Usui-Ouchi, Ayumi, et al.
Publicado: (2021)

Prediction of Visual Acuity after anti-VEGF Therapy in Diabetic Macular Edema by Machine Learning
por: Zhang, Ying, et al.
Publicado: (2022)

Expert Panel Consensus for Addressing Anti-VEGF Treatment Challenges of Diabetic Macular Edema in Spain
por: Fernández-Vigo, José Ignacio, et al.
Publicado: (2022)

Regional Variety of Reduction in Retinal Thickness of Diabetic Macular Edema after Anti-VEGF Treatment
por: Yamada, Yutaka, et al.
Publicado: (2022)

Metformin therapy as a strategy to compensate anti-VEGF resistance in patients with diabetic macular edema
por: Uwimana, Alexandre, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dc2qn0s6r92mffsumn8i1hf6u9